Envisagenics

Biomedical data might hold the key to finding the cure for currently incurable diseases. Our mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development. Our Software as a service (SaaS) to extract biologically relevant RNA isoforms from raw RNA-seq data. Discover new drug targets and biomarkers through splice isoform quantification coupled with predictive-analytics. Prioritize disease-related genes connecting your data to our databases and algorithms. Rapidly advance to experimental validation with a well supported list of targets.
Company growth
Type
Private
HQ
Huntington, US
Founded
2014
Size (employees)
4 (est)
Envisagenics was founded in 2014 and is headquartered in Huntington, US

Envisagenics Office Locations

Envisagenics has office in Huntington
Huntington, US

Envisagenics Metrics

Envisagenics Summary

Founding Date

2014

Total Funding

$225 K

Latest funding size

$225 K

Time since last funding

over 1 year

Investors

We estimate that Envisagenics's latest funding round in August 2015 was $225 K. In total, Envisagenics has raised $225 K

Envisagenics Online Presence

Envisagenics Company Life

You may also be interested in